RA CAPITAL MANAGEMENT, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for 4D MOLECULAR THERAPEUTICS, INC. Common Stock, $0.0001 par value per share (FDMT)

Filing Manager
RA CAPITAL MANAGEMENT, L.P.
Reporting Manager
RA Capital Management, L.P.
Security
4D MOLECULAR THERAPEUTICS, INC. Common Stock, $0.0001 par value per share
Symbol
FDMT
Shares outstanding
46,109,768 shares
Disclosed Ownership
4,564,867 shares
Ownership
9.9%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 18:30:15 UTC
Date of event
31 Dec 2024
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
RA Capital Management, L.P. 9.9% 4,564,867 0 4,564,867 /s/ Peter Kolchinsky By Peter Kolchinsky, Authorized Signatory
Peter Kolchinsky 9.9% 4,564,867 0 4,564,867 /s/ Peter Kolchinsky Peter Kolchinsky
Rajeev Shah 9.9% 4,564,867 0 4,564,867 /s/ Rajeev Shah Rajeev Shah
RA Capital Healthcare Fund, L.P. 9.9% 4,564,867 0 4,564,867 /s/ Peter Kolchinsky By RA Capital Healthcare Fund GP, LLC, its General Partner, By Peter Kolchinsky, Manager